C3 nephritic factor associated with C3 glomerulopathy in children

Pediatric Nephrology

Volumn 29, Issue 1, 2014, Pages 85-94

  Nicolas, Camille ^a   Vuiblet, Vincent ^a   Baudouin, Veronique ^c   Macher, Marie Alice ^c   Vrillon, Isabele ^d   Biebuyck Gouge, Nathalie ^e   Dehennault, Maud ^f   Gié, Sophie ^g   Morin, Denis ^h   Nivet, Hubert ⁱ   Nobili, François ^j   Ulinski, Tim ^k   Ranchin, Bruno ^l   Marinozzi, Maria Chiarra ^m   Ngo, Stéphanie ^b   Frémeaux Bacchi, Véronique ^b   Pietrement, Christine ^a  

^a REIMS UNIVERSITY HOSPITAL   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c HÔPITAL ROBERT DEBRÉ   (France)

^d UNIVERSITY HOSPITAL OF NANCY   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f LILLE UNIVERSITY HOSPITAL   (France)

^g RENNES UNIVERSITY HOSPITAL   (France)

^h MONTPELLIER UNIVERSITY HOSPITAL   (France)

ⁱ UNIVERSITY HOSPITAL OF TOURS   (France)

^j UNIVERSITY HOSPITAL OF BESANÇON   (France)

^k ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^l HOSPICES CIVILS DE LYON   (France)

^m CENTRE DE RECHERCHE DES CORDELIERS   (France)

more..

Author keywords

C3 glomerulonephritis; C3 glomerulopathy; Complement alternative pathway; Dense deposit disease; Membranoproliferative glomerulonephritis

Indexed keywords

COMPLEMENT FACTOR I; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MEMBRANE COFACTOR PROTEIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEPHRITIC FACTOR; RITUXIMAB; STEROID;

ACUTE KIDNEY FAILURE; ADOLESCENT; CELL PROLIFERATION; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; COMPLEMENT COMPONENT C3 GLOMERULOPATHY; FEMALE; GLOMERULOPATHY; HEMATURIA; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FAILURE; MALE; NEPHROTIC SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEINURIA; RETROSPECTIVE STUDY; REVIEW; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COMPLEMENT C3 NEPHRITIC FACTOR; FEMALE; GLOMERULONEPHRITIS; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES;

EID: 84890444436     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-013-2605-6     Document Type: Review

References (44)

1. Fakhouri F, Fremeaux-Bacchi V, Noel LH, Cook HT, Pickering MC (2010) C3 glomerulopathy: a new classification. Nat Rev Nephrol 6(8):494-499
2. Sethi S, Fervenza F, Zhang Y, Nasr S, Leung N, Vrana J, Cramer C, Nester C, Smith R (2011) Proliferative Glomerulonephritis secondary to dysfunction of the alternative pathway of complement. Clin J Am Soc Nephrol 6:1009-1017
3. Smith R, Alexander J, Barlow P (2007) New approaches to the treatment of dense deposit disease. J Am Soc Nephrol 18:2447-2456
4. Gale D, De Jorge E, Cook H (2010) Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis. Lancet 376:794-801
5. D'Agati VD, Bomback AS (2012) C3 glomerulopathy: what's in a name ? Kidney Int 82(4):379-381
6. Sethi S, Fervenza F (2011) Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification. Semin Nephrol 31(4):341-348
7. Appel G, Cook H, Hageman G, Jennette J, Kashgarian M, Kirschfink M, Lambris J, Lanning L, Lutz H, Meri S, Rose N, Salant D, Sethi S, Smith R, Smoyer W, Tully H, Tully S, Walker P, Welsh M, Würzner R, Zipfel P (2005) Membranoproliferative glomerulonephritis type II (Dense Deposit Disease): an update. J Am Soc Nephrol 16:1392-1404
8. Servais A, Fremeaux-Bacchi V, Lequintrec M, Salomon R, Blouin J, Knebelmann B, Grünfeld JP, Lesavre P, Noël LH, Fakhouri F (2007) Primary gloemrulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome. J Med Genet 44:193-199
9. Sethi S, Gamez J, Vrana J, Theis J, Ill H, Zipfel P, Dogan A, Smith R (2009) Glomeruli of dense deposit disease contain components of the alternative and terminal complement pathway. Kidney Int 75(9):952-960
10. Leroy V, Fremeaux-Bacchi V, Peuchmaur M, Baudouin V, Deschenes G, Macher MA, Loirat C (2011) Membranoproliferative glomerulonephritis with C3nef and genetic complement dysregulation. Pediatr Nephrol 26:419-424
11. Orth S, Ritz E (1998) The nephrotic syndrome. N Engl J Med 338(17):1202-1211
12. Warady B, Hebert D, Sullivan E, Alexander S, Tejani A (1997) Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents. The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 11(1):49-64
13. Rapport REIN Agence Biomedecine (2010) http://www.socnephrologie.org/ REIN/documents.htm
14. Servais A, Noël LH, Roumenina L, Le Quintrec M, Ngo S, Dragon-Durey MA, Macher MA, Zuber J, Karras A, Provot F, Moulin B, Grünfeld JP, Niaudet P, Lesavre P, Frémeaux-Bacchi V (2012) Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney Int 82:454-464
15. Sethi S, Fervenza F, Zhang Y, Zand Y, Zand L, Vrana J, Nasr S, Theis J, Dogan A, Smith R (2012) C3 glomerulopnephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment and follow-up. Kidney Int 82:465-473
16. Nasr S, Valeri A, Appel G, Sherwinter J, Stokes M, Said S, Markowitz G, D'Agati V (2009) Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients. Clin J Am Soc Nephrol 4:22-32
17. Roumenina L, Loirat C, Dragon-Durey M (2011) Alternative complement pathway assessment in patients with atypical HUS. J Immunol Methods 365:8-26
18. Fremeaux-Bacchi, Weiss L, Brun P (1994) Selective disappearance of C3NeF IgG autoantibody in the plasma of patient with membranoproliferative glomerulonephritis following renal transplantation. Nephrol Dial Transplant 9:811-814
19. Rougier N, Kazatchkine MD, Rougier JP, Fremeaux-Bacchi V, Blouin J, Deschenes G, Soto B, Baudouin V, Pautard B, Proesmans W, Weiss E, Weiss L (1998) Human complement factor H deficiency associated with hemolytic uremic syndrome. J Am Soc Nephrol 9(12):2318-2326
20. Alchi B, Jayne D (2009) Membranoproliferative glomerulonephritis. Pediatr Nephrol 25(8):1409-1418
21. Sethi S, Fervenza F (2012) Membranoproliferative glomerulonephritis - A new look at an old entity. N Engl J Med 366:1119-1131
22. Cameron J, Turner D, Heaton J, Williams D, Ogg C, Chantler C, Haycock G, Hicks J (1983) Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis. Am J Med 74(2):175-192
23. Bennett W, Fassett R, Walker R, Fairley K, D'Apice A, Kincaid-Smith P (1989) Mesangiocapillary glomerulonephritis type II (dense deposit disease): clinical features of progressive disease. Am J Kidney Dis 13(6):469-476
24. Little M, Dupont P, Campbell E, Dorman A, Walshe J (2006) Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk. Kidney Int 69(3):504-511
25. Fremeaux-Bacchi V, Weiss L, Demouchy C, May A, Palomera S, Kazatchkine M (1994) Hypocomplementaemia of poststreptococcal acute glomerulonephritis is associated with C3 nephritic (C3NeF) IgG autoantibody activity. Nephrol Dial Transplant 9(12):1747-1750
26. Sethi S, Fervenza F, Zhang Y, Zand L, Meyer N, Borsa N, Nasr S, Smith R (2013) Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement. Kidney Int 83(2):293-299
27. Vernon K, Goicoechea de Jorge E, Hall AE, Fremeaux-Bacchi V, Aitman TJ, Cook HT, Hangartner R, Koziell A, Pickering MC (2012) Acute presentation and persistent glomerulonephritis following streptococcal infection in a patient with heterozygous complement factor H-related protein 5 deficiency. Am J Kidney Dis 60(1):121-125
28. Zhang Y, Meyer N, Wang K, Nishimura C, Frees K, Jones M, Katz L, Sethi S, Smith R (2012) Causes of alternative pathway dysregulation in dense deposit disease. Clin J Am Soc Nephrol 7(22):265-274
29. Ram S, Lewis L, Rice P (2010) Infections of people with complement deficiencies and patients who have undergone splenectomy. Clin Microbiol Rev 23(4):740-780
30. Levin A (1999) Management of membranoproliferative glomerulonephritis: evidence-based recommendations. Kidney Int 70:S41-S46
31. Glassock RJ (2009) Membranoproliferative glomerulonephritis. In: Ponticelli C, Glassock RJ (eds) Treatment of primary glomerulonephritis, 2nd edn. Oxford University Press, Oxford, England, pp 375-398
32. Lu D, Moon M, Lanning LD, McCarthy A, Smith R (2012) Clinical features and outcomes of 98 children and adults with dense deposit disease. Pediatr Nephrol 27:773-781
33. McEnery (1990) Membranoproliferative glomerulonephritis: the Cincinnati experience-cumulative renal survival from 1957-1989. J Pediatr 116:S109-S114
34. Ford D, Briscoe D, Shanley P, Lum G (1992) Childhood membranoproliferative glomerulonephritis type I: limited steroid therapy. Kidney Int 41:1606-1612
35. Tarashish P, Bernstain J, Tobin J, Edelmann C (1992) Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone-a report of the International Study of Kidney Disease in Children. Pediatr Nephrol 6:123-130
36. Emre S, Sirin A, Alpay H, Tanman F, Uvsal V, Navir A, Bilge I (1995) Pulse methylprednisolone therapy in children with membranoproliferative glomerulonephritis. Acta Paediatr Jpn 37:626-629
37. Bahat E, Akkava BKS, Karpuzoglu G, Guven AG (2007) Comparison of pulse and oral steroid in childhood membranoproliferative glomerulonephritis. J Nephrol 20:234-245
38. Chapman S, Cameron J, Chantler C, Turner D (1980) Treatment of mesangiocapillary glomerulonephritis in children with combined immunosuppression and anticoagulation. Arch Dis Child 55:446-451
39. Faedda R, Satta A, Tanda F, Pirisi M, Bartoli E (1994) Immunosuppressive treatment of membranoproliferative glomerulonephritis. Nephron 67:59-65
40. Choi M, Eustace J, Gimenez L, Atta M, Scheel P, Sothinathan R, Briggs W (2002) Mycophenolate mofetil treatment for primary glomerular diseases. Kidney Int 61:1098-1114
41. Jones G, Juazczak M, Kingdon E, Harber M, Sweny P, Burns A (2004) Treatment of idiopathic membranoproliferative glomerulonephritis with mycophenolate mofetil an steroids. Nephrol Dial Transplant 19:3160-3164
42. D'Amico G, Ferrario F (1992) Mesangiocapillary glomerulonephritis. J Am Soc Nephrol 2:S159-S166
43. Sethi S, Nester C, Smith R (2012) Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion. Kidney Int 81:434-441
44. Smith R, Harris C, Pickering M (2011) Dense deposit disease. Mol Immunol 48:1604-1610